PATENT CLAIM ANALYSIS

Application Number: 16378361
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "718000"]

Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.

Claim (Index 31):
A method for treating a pediatric patient who is experiencing pulmonary hypertension and oxygen desaturation, and who is not dependent on right-to-left shunting of blood, the method comprising:\n determining whether the patient has pre-existing left ventricular dysfunction, and\n (a) if the patient does not have pre-existing left ventricular dysfunction, administering to the patient 20 ppm inhaled nitric oxide for a length of time sufficient to decrease pulmonary hypertension and improve oxygen saturation in the patient, and \n (b) if the patient does have pre-existing left ventricular dysfunction, administering inhaled supplemental oxygen to the patient and excluding the patient from treatment with inhaled nitric oxide.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.31034
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12821041', '14454373', '14451057', '12821020', '13651660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8245914074296037
- 35 USC 102 Novelty (BERT): 0.6514900972061322
- Combined Prediction Score: 0.8072812764072566
- Mean Citation Score: 668.4344120000002
- Max Citation Score: 676.1624
- Similarity Product: 597.7526319619657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test